170 related articles for article (PubMed ID: 36730538)
1. Patient Decision-Making for Management of Style 410 Anatomical Implants in Breast Reconstruction.
Boyd CJ; Salibian AA; Bekisz JM; Karp NS; Choi M
Plast Reconstr Surg; 2023 Mar; 151(3):479-485. PubMed ID: 36730538
[TBL] [Abstract][Full Text] [Related]
2. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
[TBL] [Abstract][Full Text] [Related]
3. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
Cordeiro PG; Ghione P; Ni A; Hu Q; Ganesan N; Galasso N; Dogan A; Horwitz SM
J Plast Reconstr Aesthet Surg; 2020 May; 73(5):841-846. PubMed ID: 32008941
[TBL] [Abstract][Full Text] [Related]
4. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
5. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
[TBL] [Abstract][Full Text] [Related]
6. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
7. Management of Symptomatic Patients with Textured Implants.
Asaad M; Offodile AC; Santanelli Di Pompeo F; Bevers TB; Stelly S; Carew LA; Barnea Y; Miranda RN; Butler CE; Clemens MW
Plast Reconstr Surg; 2021 May; 147(5S):58S-68S. PubMed ID: 33890882
[TBL] [Abstract][Full Text] [Related]
8. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
9. Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.
Nelson JA; McKernan CD; Rubenstein RN; Shamsunder MG; Poulton R; Dabic S; Mehrara BJ; Disa JJ; Cordeiro PG; McCarthy CM
Plast Reconstr Surg; 2023 Jul; 152(1):32-37. PubMed ID: 36728202
[TBL] [Abstract][Full Text] [Related]
10. Breast Implant-Associated Anaplastic Large Cell Lymphoma Awareness: An Analysis of the Responses to an Institutional Campaign and Global Recall.
Mason MM; Kuruoglu D; Zheng EE; Kerivan LT; Nguyen MT
Ann Plast Surg; 2023 Nov; 91(5):529-533. PubMed ID: 37823619
[TBL] [Abstract][Full Text] [Related]
11. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
Cunha A; Horta R; Barreiro D
Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
[TBL] [Abstract][Full Text] [Related]
13. The Macrotextured Implant Recall: Breast Implant-Associated-Anaplastic Large Cell Lymphoma Risk Aversion in Cosmetic and Reconstructive Plastic Surgery Practices.
Mankowski P; Carr M; Cherukupalli A; Bovill E; Lennox P; Brown MH; Carr N
Aesthet Surg J; 2022 Dec; 42(12):1408-1413. PubMed ID: 35709374
[TBL] [Abstract][Full Text] [Related]
14. Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?
Santanelli di Pompeo F; Sorotos M; Clemens MW; Paolini G; Anibaldi P; Davoli M; Baglio G; Pinnarelli L; Ferranti M; Cerza F; Cicala SD; Firmani G
Aesthetic Plast Surg; 2023 Jun; 47(3):914-926. PubMed ID: 36376583
[TBL] [Abstract][Full Text] [Related]
15. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
[TBL] [Abstract][Full Text] [Related]
16. The Influence of BIA-ALCL on the Use of Textured Breast Implant and its Placement: A Survey of Dutch Plastic Surgeons.
Bletsis PP; van Veen MM; van der Lei B
Aesthet Surg J; 2023 Jul; 43(8):NP595-NP601. PubMed ID: 36929763
[TBL] [Abstract][Full Text] [Related]
17. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
18. How Breast Implant Surface Type Is Influenced by Breast Implant-associated Anaplastic Large Cell Lymphoma: A Survey of the American Society of Plastic Surgeons.
Carr LW; Roberts J; Potochny JD
Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S208-S211. PubMed ID: 30855390
[TBL] [Abstract][Full Text] [Related]
19. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
[TBL] [Abstract][Full Text] [Related]
20. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.
McLaughlin C; Hughes AJ; Parham CS; Fritsche M; Potochny JD; Kunselman A; Ravnic DJ
Ann Plast Surg; 2022 May; 88(3 Suppl 3):S288-S292. PubMed ID: 35513333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
